FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study

BACKGROUND: Our study describes the feasibility and efficacy of a first‐line FOLFIRINOX (5‐fluorouracil [5FU], folinic acid, irinotecan, and oxaliplatin) induction chemotherapy (CT) followed by de‐escalation as a maintenance strategy for advanced pancreatic cancer. MATERIALS AND METHODS: This multic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Chevalier, Hortense, Vienot, Angélique, Lièvre, Astrid, Edeline, Julien, El Hajbi, Farid, Peugniez, Charlotte, Vernerey, Dewi, Meurisse, Aurélia, Hammel, Pascal, Neuzillet, Cindy, Borg, Christophe, Turpin, Anthony
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2020
Aiheet:
Gastrointestinal Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648331/
https://ncbi.nlm.nih.gov/pubmed/32886823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0577
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia